Related topics: patent · food and drug administration · drug

Research shows moves to ban pay-to-delay deals are justified

Controversial deals that delay generic versions of drugs coming onto the market can lead to consumers paying significantly more for some treatments, according to new research by an academic from the University of East Anglia ...